MS in Drug Discovery and Development at Drexel University

USD 63,200

Drexel University, USA

Type: Masters Duration: 2.0 years

Explore the MS in Drug Discovery and Development program at Drexel University. This program is offered in USA and provides an excellent learning opportunity in Masters studies.

Drexel University offers an online Master of Science (MS) in Drug Discovery and Development designed to equip students with the essential skills and knowledge required for success in the pharmaceutical and biotechnology industries. This program covers the entire drug development process, from discovery through to FDA review and post-market monitoring. Students will engage with a rigorous curriculum that includes core courses such as Graduate Pharmacology and Drug Discovery and Development, alongside a wide selection of over 50 electives that allow for customization based on individual interests. The program is 100% online, making it accessible for working professionals, and can be completed in as little as two years, although most students take two and a half to three years. Graduates are well-prepared for various roles in drug discovery, clinical research, and regulatory affairs, among others, and benefit from networking opportunities with industry professionals.

University
Drexel University
University Location
USA (Online)
Program Duration
2.0 years
Ranking
#727
Part-time allowed
Yes

Required Courses
  • Responsible Conduct of Research
  • Statistics for Neuro/Pharm Research
  • Graduate Pharmacology
  • Drug Discovery and Development I
  • Drug Discovery and Development II
  • Current Topics in Drug Discovery and Development
  • Research in Drug Discovery and Development
Elective Courses
  • Biologics
  • Biomarkers
  • Business Development
  • Clinical Development
  • Commercialization and Marketing
  • Computer Aided Drug Design
  • Entrepreneurship
  • Formulation
  • High Throughput Screening
  • IND Application
  • Intellectual Property
  • Lead Optimization
  • Medical Writing
  • New Drug Application
  • Peptide Therapeutics
  • Pharmaceutical Manufacturing
  • Pharmacoepidemiology
  • Pharmacogenomics
  • Pharmacovigilance
  • Program and Portfolio Management
  • Safety and Toxicology
  • Target Identification
  • Target Validation
  • Translational Medicine
  • Use of Animal Models
  • Vaccines